Abstract

PurposeA new kind of coronavirus, the SARS-CoV-2, started the biggest pandemic of the century. More than a million people have been killed by Covid-19. Because of this, quick and precise diagnosis test is necessary. The current gold standard is the RT-PCR with DNA sequencing and identification, but its results take too long to be available. Tests base on IgM/IgG antibodies have been used, but their sensitivity and specificity may be very low. Many studies have been demonstrating the Covid-19 impact on hematological parameters.MethodThis work proposes an intelligent system to support Covid-19 diagnosis based on blood testing. Laboratory parameters obtained from the hemogram and biochemical tests defined as standards to support clinical diagnosis were used as input features. Afterward, we used particle swarm optimization, evolutionary algorithms, and manual selection based on cost minimization to select the most significant features.ResultsWe tested several machine learning methods, and we achieved high classification performance: overall accuracy of 95.159% ± 0.693, kappa index of 0.903 ± 0.014, sensitivity of 0.968 ± 0.007, precision of 0.938 ± 0.010, and specificity of 0.936 ± 0.011. These results were achieved using classical and low computational cost classifiers, with Bayes Network being the best of them. In addition, only 24 blood tests were needed.ConclusionThis points to the possibility of a new rapid test with low cost. The desktop version of the system is fully functional and available for free use.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.